Efficiency of Biomarker-Driven Clinical Trial Designs

J Clin Oncol. 2024 Apr 20;42(12):1454-1455. doi: 10.1200/JCO.23.02581. Epub 2024 Mar 4.

Authors

Boris Freidlin¹, Edward L Korn¹

Affiliation

¹ Boris Freidlin, PhD and Edward L. Korn, PhD, Biostatistics Branch, Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.

PMID: 38437594
PMCID: PMC11095868 (available on 2025-04-20)
DOI: 10.1200/JCO.23.02581

No abstract available

Publication types

Letter

MeSH terms

Biomarkers, Tumor*
Clinical Trials as Topic
Humans
Research Design*

Substances

Biomarkers, Tumor